138 related articles for article (PubMed ID: 2536882)
41. Identification of functional platelet-activating factor receptors in Raji lymphoblasts.
Travers JB; Li Q; Kniss DA; Fertel RH
J Immunol; 1989 Dec; 143(11):3708-13. PubMed ID: 2555416
[TBL] [Abstract][Full Text] [Related]
42. High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes.
Hwang SB
Eur J Pharmacol; 1991 Apr; 196(2):169-75. PubMed ID: 1651872
[TBL] [Abstract][Full Text] [Related]
43. Evidence for the presence of the platelet-activating factor receptor in the CFW mouse preimplantation two-cell-stage embryo.
Roudebush WE; LaMarche MD; Levine AS; Jiang H; Butler WJ
Biol Reprod; 1997 Sep; 57(3):575-9. PubMed ID: 9282993
[TBL] [Abstract][Full Text] [Related]
44. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
45. Distinct biochemical responses of hepatic macrophages and endothelial cells to platelet-activating factor during endotoxemia.
Gardner CR; Laskin JD; Laskin DL
J Leukoc Biol; 1995 Feb; 57(2):269-74. PubMed ID: 7852841
[TBL] [Abstract][Full Text] [Related]
46. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
47. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line.
Dupuis F; Levasseur S; Jean-Louis F; Dulery C; Praloran V; Denizot Y; Michel L
Biochim Biophys Acta; 1997 Dec; 1359(3):241-9. PubMed ID: 9434130
[TBL] [Abstract][Full Text] [Related]
48. Platelet-activating factor receptor-mediated calcium influx in NG 108-15 cells.
Chau LY; Hu CY
Chin J Physiol; 1993; 36(1):57-63. PubMed ID: 8275798
[TBL] [Abstract][Full Text] [Related]
49. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
Bito H; Kudo Y; Shimizu T
J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
51. Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action.
Yamazaki M; Gomez-Cambronero J; Durstin M; Molski TF; Becker EL; Sha'afi RI
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5791-4. PubMed ID: 2548188
[TBL] [Abstract][Full Text] [Related]
52. Evidence for platelet-activating factor receptors in several B lymphoblastoid cell lines.
Travers JB; Shaw JE; Li Q; Kniss DA; Fertel RH
Life Sci; 1991; 49(23):1755-60. PubMed ID: 1658521
[TBL] [Abstract][Full Text] [Related]
53. Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells.
Chau LY; Peck K; Yen HH; Wang JY
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):911-6. PubMed ID: 7519853
[TBL] [Abstract][Full Text] [Related]
54. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
James-Kracke MR; Sexe RB; Shukla SD
J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
[TBL] [Abstract][Full Text] [Related]
55. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils.
Kroegel C; Yukawa T; Westwick J; Barnes PJ
Biochem Biophys Res Commun; 1989 Jul; 162(1):511-21. PubMed ID: 2546554
[TBL] [Abstract][Full Text] [Related]
56. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
Heymans F; Steiner E; Jouquey S; Godfroid JJ
J Lipid Mediat; 1989; 1(5):303-12. PubMed ID: 2562436
[TBL] [Abstract][Full Text] [Related]
57. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites.
Müller S; Nigam S
Biochem Biophys Res Commun; 1992 Dec; 189(2):771-6. PubMed ID: 1335246
[TBL] [Abstract][Full Text] [Related]
58. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K
J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248
[TBL] [Abstract][Full Text] [Related]
59. Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons.
Bito H; Nakamura M; Honda Z; Izumi T; Iwatsubo T; Seyama Y; Ogura A; Kudo Y; Shimizu T
Neuron; 1992 Aug; 9(2):285-94. PubMed ID: 1323312
[TBL] [Abstract][Full Text] [Related]
60. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line.
Kuruvilla A; Putcha G; Poulos E; Shearer WT
J Immunol; 1993 Jul; 151(2):637-48. PubMed ID: 8393037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
